journal
Journals International Forum of Allergy...

International Forum of Allergy & Rhinology

https://read.qxmd.com/read/38648256/endoscopic-surgical-field-clarity-index-an-artificial-intelligence-based-measure-of-transnasal-endoscopic-surgical-field-quality
#1
JOURNAL ARTICLE
John N Poche, Stephen C Hernandez, Katie L Melder, Michael E Dunham, Daniel W Nuss, Zhide Fang
Clear visualization during transnasal endoscopic surgery (TNES) is crucial for safe, efficient surgery. The endoscopic surgical field clarity index (ESFCI) is an artificial intelligence-enabled measure of surgical field quality. The ESFCI allows researchers to evaluate interventions to improve visualization during TNES.
April 22, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38646913/comparison-of-patient-reported-outcomes-and-clinical-characteristics-among-patients-with-pituitary-macroadenomas-and-giant-adenomas
#2
JOURNAL ARTICLE
Jessa E Miller, Hye Rhyn Chung, Benjamin R Uy, Nikitha Kosaraju, Ryan M Shih, Myungjun Ko, Shannon R Esswein, Arash Abiri, Pooya Khosravi, Nolan Huck, Cecilia H Nguyen, Timothy Hsu, Michael G Kim, Frank P K Hsu, Won Kim, Jivianne K Lee, Jeffrey D Suh, Marvin Bergsneider, Edward C Kuan, Marilene B Wang
Patients with giant adenomas are more likely to have tumor extension into the paranasal sinuses. Compared to macroadenomas, giant adenomas are not associated with worse preoperative SNOT-22 scores.
April 22, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38623035/correspondence-to-the-editor-regarding-air-pollution-exposure-is-associated-with-rhinitis-in-older-us-adults-via-specific-immune-mechanisms
#3
LETTER
Hyun Jin Min
No abstract text is available yet for this article.
April 16, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38618980/the-relationship-between-survey-based-subjective-olfactory-awareness-and-objective-olfactory-function
#4
JOURNAL ARTICLE
Aurelia S Monk, Shreyas Pyati, Meredith Lamb, Nick Melott, Ezer H Benaim, Christoper Wiesen, Cristine Klatt-Cromwell, Brian D Thorp, Charles S Ebert, Adam J Kimple, Brent A Senior
Correlation between symptom-based surveys and objective olfactory testing is variable. For diagnosis and symptom monitoring, surveys should correlate with objective testing. The Odor Awareness Scale (OAS) and Affective Importance of Odor Scale (AIO) showed significant but moderate positive correlations with University of Pennsylvania Scent Identification Test (UPSIT) score.
April 15, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38616565/evaluating-olfactory-function-and-quality-of-life-in-patients-with-traumatic-brain-injury
#5
JOURNAL ARTICLE
Amelia S Lawrence, Rahul Alapati, Sarah F Wagoner, Antonio Bon Nieves, Cole Bird, Robert Wright, Shah Jafri, Michael Rippee, Jennifer A Villwock
Patients with traumatic brain injury (TBI) had worse olfactory quality of life (QoL) and Sino-Nasal Outcome Test-22 scores compared to a normal cohort. A worse olfactory QoL correlated with concussion symptom burden. Olfactory dysfunction among TBI patients should be addressed to improve overall outcomes.
April 14, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38616557/sinonasal-microbiota-transfer-to-treat-recalcitrant-chronic-rhinosinusitis-a-case-series
#6
JOURNAL ARTICLE
Sandeep K Gill, Juan C Hernaiz-Leonardo, Thaddeus J Edens, Athenea Pascual, Chris Tang, Judy Fan, Andrew Thamboo, Warren Mullings, Saad Alsaleh, Bader M Alim, Amin R Javer, Amee R Manges
SinoNasal Microbiota Transfer (SNMT) was safe with immediate benefit in all recipients, with sustained improvement in two of three recipients for up to 180 days. The addition of antimicrobial photodynamic therapy worsened chronic rhinosinusitis. These promising SNMT results warrant further study of safety and efficacy.
April 14, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38584570/patients-with-parosmia-respond-faster-to-unpleasant-odors-than-patients-with-hyposmia-insights-from-olfactory-event-related-potentials
#7
JOURNAL ARTICLE
Zetian Li, Luisa Richter, Tanja Krueger, Herbert Eichwald, Antje Hähner, Thomas Hummel
BACKGROUND: Diagnosing parosmia is a challenge. The present study aimed to explore the distinctions between hyposmic patients with and without parosmia utilizing electroencephalography-derived olfactory event-related potentials (ERP). METHODS: Forty-four patients with hyposmia were enrolled and divided into a group with parosmia (n = 23, mean age ± standard deviation = 48 ± 14 years, seven men) and a group without parosmia (n = 21, age = 52 ± 12 years, seven men) based on the clinical interview...
April 8, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38567900/recurrence-morbidity-of-olfactory-neuroblastoma
#8
JOURNAL ARTICLE
Katie Melder, Jess C Mace, Garret Choby, Joao Paulo Almeida, Pierre-Olivier Champagne, Erik Chan, Jeremy Ciporen, Mark B Chaskes, Juan Fernandez-Miranda, Nicholas K Fung, Paul Gardner, Peter Hwang, Keven Seung Yong Ji, Aristotelis Kalyvas, Keonho A Kong, Chirag Patel, Zara Patel, Maria Peris Celda, Carlos D Pinheiro-Neto, Carl Snyderman, Brian D Thorp, Jamie J Van Gompel, Georgios Zenonos, Nathan T Zwagerman, Olabisi Sanusi, Eric W Wang, Mathew Geltzeiler
BACKGROUND: With modern treatment paradigms, olfactory neuroblastoma (ONB) has favorable overall survival (OS); however, the incidence of recurrence remains high. The primary aims of this study were to delineate the prognosis of recurrence of ONB and explore how recurrence subsites are associated with OS, disease-specific survival (DSS), and further recurrence. METHODS: A retrospective chart review of ONB cases from nine academic centers between 2005 and 2021 was completed...
April 3, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38555579/evaluating-health-utility-score-through-direct-and-indirect-methods-in-patients-with-chronic-rhinosinusitis
#9
JOURNAL ARTICLE
Wirach Chitsuthipakorn, Narissara Pracharktam, Juthaporn Phetpong, Patlada Kowatanamongkon, Kittichai Mongkolkul, Kornkiat Snidvongs
INTRODUCTION: EuroQol-5-dimensions-5-levels (EQ-5D-5L), visual analog scale (VAS), time trade-off (TTO), and standard gamble (SG) are used for the assessment of Health Utility Scores (HUS) of chronic rhinosinusitis (CRS). This study aimed to determine the overall HUS of CRS, the factors which influence the HUS, and the preferable method. METHODS: A cross-sectional study was conducted. Patients with primary CRS were recruited. Clinical and socioeconomic data together with HUS were assessed...
March 31, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38553891/american-rhinologic-society-expert-practice-statement-part-1-skull-base-reconstruction-following-endoscopic-skull-base-surgery
#10
JOURNAL ARTICLE
Jennifer E Douglas, Nithin D Adappa, Garret Choby, Corinna G Levine, Mindy R Rabinowitz, Raj Sindwani, Eric W Wang, Bradford A Woodworth, Edward C Kuan
The goal of this American Rhinologic Society expert practice statement (EPS) is to summarize the best available evidence for technical factors that optimize outcomes in skull base reconstruction following endoscopic skull base surgery for intradural pathologies. These topics include the use of free mucosal grafts versus vascularized pedicled nasoseptal flaps; the use of autologous versus synthetic grafts; and the roles of lumbar drains, dural sealants, and nasal packing. This EPS was developed following the recommended methodology and approval process as previously outlined...
March 30, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38526947/detection-of-plagiarism-among-rhinology-scientific-journals
#11
JOURNAL ARTICLE
Ezer H Benaim, Saima Wase, Saif Zaidi, Aurelia Monk, Cristine Klatt-Cromwell, Brian D Thorp, Charles S Ebert, Adam J Kimple, Brent A Senior
Automated plagiarism-checking software can be a valuable tool for detecting plagiarism in manuscripts. Twenty-five of 60 articles (42%) had at least one incidence of plagiarism, predominately text recycling. A "similarity score" ranging from 22% to 35% could be a potential cut-off value when screening submitted manuscripts.
March 25, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38526915/treatment-of-unilateral-olfactory-neuroblastoma-appropriate-extent-of-surgical-resection-and-potential-for-olfactory-preservation
#12
JOURNAL ARTICLE
Harish Dharmarajan, Garret Choby, Ralph Abi Hachem, Edward C Kuan, Corinna G Levine, Olabisi Sanusi, Theodore Schuman, Dennis Tang, Michael Yim, Mathew Geltzeiler
Historically, comprehensive surgical resection for olfactory neuroblastoma has included the bilateral olfactory epithelium, cribriform plate, overlying dura, olfactory bulbs and tracts. This results in postoperative anosmia that may significantly impact a patient's quality of life without definitive added benefit in survival. The prevalence of occult intracranial disease is low, especially for Hyams grade I and II tumors. A unilateral approach sparing the contralateral cribriform plate and olfactory system can be considered for select cases of early stage, low-grade tumors when the disease does not cross midline to involve the contralateral olfactory cleft or septal mucosa and when midline dural margins can be cleared with frozen pathology...
March 25, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38477174/double-blind-randomized-controlled-trial-measuring-the-efficacy-of-nebulized-steroid-at-half-dose-in-comparison-to-high-volume-squeeze-bottle-steroid-irrigation-in-management-of-patients-with-chronic-rhinosinusitis
#13
JOURNAL ARTICLE
Anna Megow, George Bouras, Eng H Ooi, Sarah Vreugde, Alkis Psaltis, Peter-John Wormald
Nebulized budesonide is effective at half dose compared to budesonide irrigation in CRS. Nasal nebulizers provide an alternative for delivery of topical steroids to the sinuses.
March 13, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38477154/a-novel-staging-system-to-consolidate-silent-sinus-syndrome-and-chronic-maxillary-atelectasis-a-systematic-review-and-case-series
#14
JOURNAL ARTICLE
Dev Amin, Shreya Mandloi, Kathryn Nunes, Neha Garg, Chase Kahn, Alexander Duffy, Elina Toskala, Mindy Rabinowitz, Marc Rosen, Gurston Nyquist
Silent sinus syndrome (SSS) and chronic maxillary atelectasis (CMA) represent an overlapping clinical entity, both likely lying on the spectrum of one disease process. There is widespread inconsistency of diagnosis in the literature of reported cases of SSS and CMA. We propose a novel, comprehensive staging system to simplify diagnosis and inform management.
March 13, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38465800/the-inflation-reduction-act-implications-for-medicare-spending-and-access-to-biologic-therapies-for-chronic-rhinosinusitis-with-nasal-polyposis-and-asthma
#15
JOURNAL ARTICLE
Vinay K Rathi, Zachary M Soler, Rodney J Schlosser, Alan D Workman, Nikita Chapurin, Nicholas R Rowan, Stacie B Dusetzina
In 2021, Medicare spending on biologics was $926 million in Part B (FFS) and $1.3 billion in Part D (FFS/MA). Between 2017 and 2021, annual Medicare spending on biologics increased by approximately 200%. Between 2023 and 2025, Medicare Part D OOP costs for biologics will decrease by an estimated 50%-60%.
March 11, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38465788/dupilumab-prevents-nasal-epithelial-function-alteration-by-il-4-in-vitro-evidence-for-its-efficacy
#16
JOURNAL ARTICLE
Maxime Fieux, Florent Carsuzaa, Yvan Bellanger, Sophie Bartier, Virginie Fournier, Jean Claude Lecron, Matthieu Bainaud, Bruno Louis, Stéphane Tringali, Xavier Dufour, André Coste, Laure Favot, Emilie Bequignon
BACKGROUND: Chronic rhinosinusitis with nasal polyp (CRSwNP) is a typical type 2 inflammation involving interleukin (IL)-4 and IL-13. Dupilumab is a fully human monoclonal antibody targeting IL-4 receptor α subunit, thereby blocking signaling by both cytokines. Our hypothesis was that IL-4 and IL-13, by inducing a severe epithelial dysregulation, are involved in CRSwNP pathogenesis. This study aimed to evaluate the in vitro direct effect of IL-4, IL-13, and dupilumab on nasal epithelial functions...
March 11, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38465787/combined-balloon-eustachian-tuboplasty-endoscopic-sinus-surgery-for-patients-with-chronic-rhinosinusitis-and-eustachian-tube-dysfunction
#17
JOURNAL ARTICLE
Cheng-Yu Hsieh, Wei-Chieh Lin, Chung-Ching Lin, Yi-Fan Chou
BACKGROUND: To elucidate the role of balloon Eustachian tuboplasty (BET) in the management of chronic rhinosinusitis with obstructive Eustachian tube dysfunction (ETD), we evaluated the results of endoscopic sinus surgery (ESS) with and without BET in patients with chronic rhinosinusitis with obstructive ETD. METHODS: This randomized controlled trial conducted in a single-institution tertiary care center setting included 50 patients diagnosed with primary chronic rhinosinusitis and obstructive ETD between July 2018 and June 2022...
March 11, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38409897/medication-utilization-for-patients-with-chronic-rhinosinusitis-with-nasal-polyposis-and-asthma-in-12-months-pre-and-post-dupilumab-initiation
#18
LETTER
Emily Garvey, Bita Naimi, Alexander Duffy, Chase Kahn, Douglas Farquhar, Marc Rosen, Mindy Rabinowitz, Damaris Pena Evertz, Jessica Most, Elina Toskala, Gurston G Nyquist
This study examines the impact of dupilumab on medication use for chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma patients. Patients on dupilumab had a reduction in oral/inhaled/topical steroids, antibiotics, and leukotriene receptor antagonists (LTRAs). The reduction in medication use had no impact on total polyp or SNOT-22 scores.
February 26, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38400591/the-effect-of-pm2-5-on-acute-sinusitis-a-population-based-study
#19
JOURNAL ARTICLE
David Grimm, Z Jason Qian, Michael Yong, Peter H Hwang
PM2.5 exposure is a risk factor for the development of acute sinusitis. PM2.5 exposure affects acute sinusitis in a dose response fashion.
February 23, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38372441/snot-22-subdomain-outcomes-following-treatment-for-sinonasal-malignancy-a-prospective-multicenter-study
#20
JOURNAL ARTICLE
David R Grimm, Daniel M Beswick, Sabrina L Maoz, Eric W Wang, Garret W Choby, Edward C Kuan, Erik P Chan, Nithin D Adappa, Mathew Geltzeiler, Anne E Getz, Ian M Humphreys, Christopher H Le, Waleed M Abuzeid, Eugene H Chang, Aria Jafari, Todd T Kingdom, Michael A Kohanski, Jivianne K Lee, Jayakar V Nayak, James N Palmer, Zara M Patel, Carlos D Pinheiro-Neto, Adam C Resnick, Myung S Sim, Timothy L Smith, Carl H Snyderman, Maie A John, Phillip Storm, Jeffrey D Suh, Marilene B Wang, Peter H Hwang
BACKGROUND: Patients with sinonasal malignancy (SNM) present with significant sinonasal quality of life (QOL) impairment. Global sinonasal QOL as measured by the 22-item Sinonasal Outcomes Test (SNOT-22) has been shown to improve with treatment. This study aims to characterize SNOT-22 subdomain outcomes in SNM. METHODS: Patients diagnosed with SNM were prospectively enrolled in a multi-center patient registry. SNOT-22 scores were collected at the time of diagnosis and through the post-treatment period for up to 5 years...
February 19, 2024: International Forum of Allergy & Rhinology
journal
journal
43383
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.